- Home
- MRVI vs NEWT Comparison
MRVI vs NEWT Comparison
Compare MRVI & NEWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- NEWT
- Stock Information
- Founded
- MRVI 2014
- NEWT 1998
- Country
- MRVI United States
- NEWT United States
- Employees
- MRVI 560
- NEWT N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- NEWT Major Banks
- Sector
- MRVI Health Care
- NEWT Finance
- Exchange
- MRVI Nasdaq
- NEWT Nasdaq
- Market Cap
- MRVI 350.1M
- NEWT 294.8M
- IPO Year
- MRVI 2020
- NEWT N/A
- Fundamental
- Price
- MRVI $2.42
- NEWT $12.37
- Analyst Decision
- MRVI Hold
- NEWT Hold
- Analyst Count
- MRVI 10
- NEWT 4
- Target Price
- MRVI $5.84
- NEWT $13.00
- AVG Volume (30 Days)
- MRVI 1.5M
- NEWT 188.9K
- Earning Date
- MRVI 08-11-2025
- NEWT 07-28-2025
- Dividend Yield
- MRVI N/A
- NEWT 6.14%
- EPS Growth
- MRVI N/A
- NEWT 21.23
- EPS
- MRVI N/A
- NEWT 2.01
- Revenue
- MRVI $219,830,000.00
- NEWT $364,004,000.00
- Revenue This Year
- MRVI N/A
- NEWT N/A
- Revenue Next Year
- MRVI $7.23
- NEWT $12.73
- P/E Ratio
- MRVI N/A
- NEWT $6.15
- Revenue Growth
- MRVI N/A
- NEWT 20.91
- 52 Week Low
- MRVI $1.67
- NEWT $9.12
- 52 Week High
- MRVI $9.60
- NEWT $15.49
- Technical
- Relative Strength Index (RSI)
- MRVI 49.60
- NEWT 61.20
- Support Level
- MRVI $2.28
- NEWT $12.16
- Resistance Level
- MRVI $2.47
- NEWT $12.48
- Average True Range (ATR)
- MRVI 0.14
- NEWT 0.27
- MACD
- MRVI -0.01
- NEWT 0.02
- Stochastic Oscillator
- MRVI 27.45
- NEWT 73.00
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About NEWT NewtekOne Inc.
NewtekOne Inc is a financial holding company engaged in providing financial solutions to its Client Base. It is an internally managed non-diversified closed-end management investment company. It has four reportable segments Banking, Alternative Lending, Technology, NSBF, and Payments.